FSTL3 and non-small cell lung carcinoma: Additional research identified a binding site for miR-122-5p in the 3ʹ-UTR of Follistatin like 3 (FSTL3), along with a negative correlation between FSTL3 expression and miR-122-5p in samples from NSCLC patients.